All Stories

  1. SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE)

    Article • PLOS One, August 2025, PLOS

    Gerald Evans

  2. Antiviral therapy for HPAI and reported oseltamivir resistance in Canada

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, June 2025, University of Toronto Press (UTPress)

    Gerald Evans

  3. Anti-SARS-CoV-2 antibody levels in a cohort of health care workers before and after the Omicron wave in Canada

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, June 2025, University of Toronto Press (UTPress)

    Gerald Evans

  4. Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015–2022

    Article • Emerging Infectious Diseases, June 2025, Centers for Disease Control and Prevention (CDC)

    Gerald Evans

  5. Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial

    Article • EClinicalMedicine, May 2025, Elsevier

    Gerald Evans

  6. Increasing evidence-based care practices for patients with Staphylococcus aureus bacteraemia through required infectious diseases consultation in a tertiary care hospital: a quality improvement initiative

    Article • BMJ Open Quality, April 2025, BMJ

    Gerald Evans

  7. Impact of Antibiotic Duration on Gut Microbiome Composition and Antimicrobial Resistance: A Substudy of the BALANCE Randomized Controlled Trial

    Article • Open Forum Infectious Diseases, February 2025, Oxford University Press (OUP)

    Gerald Evans

  8. SCORE: Serologic Evidence of COVID-19, Social, and Occupational Contacts in Healthcare Workers in a Sample of Long-Term Care and Acute Care Facilities in Southeastern Ontario (SCORE)

    Article • May 2024, Cold Spring Harbor Laboratory Press

    Gerald Evans

  9. Epidemiology and clinical manifestations of reported Lyme disease cases: Data from the Canadian Lyme disease enhanced surveillance system

    Article • PLOS One, December 2023, PLOS

    Gerald Evans

  10. AMMI Canada 2023 update on influenza: Management and emerging issues

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, November 2023, University of Toronto Press (UTPress)

    Gerald Evans

  11. Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study

    Article • PLOS One, June 2023, PLOS

    Gerald Evans

  12. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia

    Article • Redox Biology, December 2022, Elsevier

    Gerald Evans

  13. Trends in Clostridioides difficile infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemic

    Article • Infection Control, August 2022, Cambridge University Press

    Gerald Evans

  14. Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019

    Article • Emerging Infectious Diseases, June 2022, Centers for Disease Control and Prevention (CDC)

    Gerald Evans

  15. 2021–2022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, March 2022, University of Toronto Press (UTPress)

    Gerald Evans

  16. Low yield of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic routine screen testing, despite high community incidence

    Article • Infection Control, June 2021, Cambridge University Press

    Gerald Evans

  17. Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada

    Article • Scientific Reports, February 2021, Springer Science + Business Media

    Gerald Evans

  18. The pitfalls of mass hospital health care worker testing for COVID-19

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, October 2020, University of Toronto Press (UTPress)

    Gerald Evans

  19. Guidance on the use of antiviral agents for the 2019–2020 influenza season

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, June 2020, University of Toronto Press (UTPress)

    Gerald Evans

  20. COVID-19 and cancer: do we really know what we think we know?

    Article • Nature Reviews Clinical Oncology, May 2020, Springer Science + Business Media

    Gerald Evans

  21. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

    Article • Nature Reviews Clinical Oncology, April 2020, Springer Science + Business Media

    Gerald Evans

  22. Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016

    Article • Antimicrobial Resistance and Infection Control, February 2020, Springer Science + Business Media

    Gerald Evans

  23. Long-Term Sequelae and Health-Related Quality of Life Associated With Lyme Disease: A Systematic Review

    Article • Clinical Infectious Diseases, November 2019, Oxford University Press (OUP)

    Gerald Evans

  24. Use of antiviral drugs for seasonal influenza: Foundation document for practitioners—Update 2019

    Article • Journal of the Association of Medical Microbiology and Infectious Disease Canada, June 2019, University of Toronto Press (UTPress)

    Gerald Evans

  25. Estimating direct healthcare costs attributable to laboratory‐confirmed Lyme disease in Ontario, Canada: A population‐based matched cohort study using health administrative data

    Article • Zoonoses and Public Health, January 2019, Wiley

    Gerald Evans

  26. Combined treatment methods are needed to treat a rare lung infection.

    Article • Canadian Journal of Respiratory Critical Care and Sleep Medicine, March 2018, Taylor & Francis

    Gerald Evans

  27. Human granulocytic anaplasmosis acquired from a blacklegged tick in Ontario

    Article • Canadian Medical Association Journal, March 2018, Canadian Medical Association (CMA)

    Gerald Evans

  28. A Longitudinal Four-year Pre-Post Intervention Study Evaluating the Use of an Antimicrobial Stewardship Application

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Gerald Evans

  29. Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci

    Article • Infection Control, November 2016, Cambridge University Press

    Camille Lemieux, Gerald Evans

  30. Sexual behaviors among women living with HIV in Ontario, Canada

    Article • AIDS Care, September 2016, Taylor & Francis

    Gerald Evans

  31. Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era

    Article • AIDS Care, July 2016, Taylor & Francis

    Gerald Evans

  32. Adequacy of Mental Health Services for HIV-Positive Patients with Depression: Ontario HIV Treatment Network Cohort Study

    Article • PLOS One, June 2016, PLOS

    Gerald Evans

  33. Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys

    Article • Antimicrobial Resistance and Infection Control, May 2016, Springer Science + Business Media

    Gerald Evans

  34. Lyme disease: How reliable are serologic results?

    Article • Canadian Medical Association Journal, August 2015, Canadian Medical Association (CMA)

    Gerald Evans

  35. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada

    Article • BMC Infectious Diseases, August 2015, Springer Science + Business Media

    Gerald Evans

  36. Comparison of coping strategies and supports between aboriginal and non-aboriginal people living with HIV in Ontario

    Article • AIDS Care, August 2015, Taylor & Francis

    Gerald Evans

  37. Guidance for Practitioners on the Use of Antiviral Drugs to Control Influenza Outbreaks in Long-Term Care Facilities in Canada, 2014-2015 Season

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2015, Hindawi Publishing Corporation

    Gerald Evans

  38. Guidance on The Use of Antiviral Drugs for Influenza in Acute Care Facilities in Canada, 2014-2015

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2015, Hindawi Publishing Corporation

    Gerald Evans

  39. The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases

    Article • Medical Decision Making, December 2014, SAGE Publications

    Gerald Evans

  40. Toward a Functional Definition of a “Rare Disease” for Regulatory Authorities and Funding Agencies

    Article • Value in Health, December 2014, Elsevier

    Gerald Evans

  41. Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases

    Article • Journal of General Internal Medicine, July 2014, Springer Science + Business Media

    Gerald Evans

  42. Opportunity Cost of Funding Drugs for Rare Diseases

    Article • Medical Decision Making, July 2014, SAGE Publications

    Gerald Evans

  43. The Vioxx® legacy: Enduring lessons from the not so distant past

    Article • Cardiology Journal, April 2014, VM Media SP. zo.o VM Group SK

    Gerald Evans

  44. Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole

    Article • PLOS One, January 2014, PLOS

    Dr Mark Miller, Dr Allison McGeer, Gerald Evans

  45. A confusing Case –Weissella confusaProsthetic Joint Infection: A Case Report and Review of the Literature

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2014, Hindawi Publishing Corporation

    Gerald Evans

  46. Renal Failure, Hepatitis and Myocarditis in A Previously Healthy Man

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2014, Hindawi Publishing Corporation

    Gerald Evans

  47. Microbial source tracking and spatial analysis of E. coli contaminated private well waters in southeastern Ontario

    Article • Journal of Water and Health, December 2013, IWA Publishing

    Gerald Evans

  48. The Velvet Myocardium: Potential Harbinger of Death in Acute Myocarditis?

    Article • Canadian Journal of Cardiology, December 2013, Elsevier

    Gerald Evans

  49. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009

    Article • Journal of Antimicrobial Chemotherapy, March 2013, Oxford University Press (OUP)

    Dr Allison McGeer, Gerald Evans

  50. Application of Operations Research to Funding Decisions for Treatments with Rare Disease

    Article • January 2013, Springer Science + Business Media

    Gerald Evans

  51. Emergency Department Surveillance as a Proxy For The Prediction of Circulating Respiratory Viral Disease in Eastern Ontario

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2013, Hindawi Publishing Corporation

    Gerald Evans

  52. An Evaluation Framework for Funding Drugs for Rare Diseases

    Article • Value in Health, September 2012, Elsevier

    Gerald Evans

  53. Acute orbital inflammatory syndrome following H1N1 immunization

    Article • Canadian Journal of Ophthalmology, December 2011, Elsevier

    Gerald Evans

  54. Canadian clinical practice guidelines for acute and chronic rhinosinusitis

    Article • Allergy Asthma & Clinical Immunology, February 2011, Springer Science + Business Media

    Gerald Evans

  55. Canadian Practice Guidelines for Surgical Intra-Abdominal Infections

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2010, Hindawi Publishing Corporation

    Gerald Evans

  56. Health technology assessment: A comprehensive framework for evidence-based recommendations in Ontario

    Article • International Journal of Technology Assessment in Health Care, April 2009, Cambridge University Press

    Gerald Evans

  57. Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2008, Hindawi Publishing Corporation

    Gerald Evans

  58. Impact of a Fluoroquinolone Restriction Policy in an Elderly Population

    Article • The American Journal of Medicine, October 2007, Elsevier

    Gerald Evans

  59. RETIRED: Canadian Consensus Guidelines on Human Papillomavirus

    Article • Journal of Obstetrics and Gynaecology Canada, August 2007, Elsevier

    Gerald Evans

  60. Laboratory diagnosis of human infection with avian influenza

    Article • Canadian Medical Association Journal, November 2006, Canadian Medical Association (CMA)

    Gerald Evans

  61. Complicated Urinary Tract Infection in Adults

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2005, Hindawi Publishing Corporation

    Gerald Evans

  62. HYPERSENSITIVITY REACTION ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR INTERSTITIAL CYSTITIS

    Article • The Journal of Urology, August 2004, Wolters Kluwer Health

    Gerald Evans

  63. The Management of Infection and Colonization due to Methicillin-ResistantStaphylococcus aureus: A CIDS/CAMM Position Paper

    Article • Canadian Journal of Infectious Diseases, January 2004, Hindawi Publishing Corporation

    Gerald Evans

  64. Infection Control for the Otolaryngologist in the Era of Severe Acute Respiratory Syndrome

    Article • The Journal of Otolaryngology, January 2003, Decker, Inc.

    Gerald Evans

  65. The oxazolidinones

    Article • Current Infectious Disease Reports, January 2002, Springer Science + Business Media

    Gerald Evans

  66. Macrolides: A Canadian Infectious Disease Society Position Paper

    Article • Canadian Journal of Infectious Diseases, January 2001, Hindawi Publishing Corporation

    Gerald Evans

  67. Antimicrobial Regimens Prescribed by Canadian Physicians for Chemotherapy-Induced Febrile Neutropenic Episodes

    Article • Canadian Journal of Infectious Diseases, January 1999, Hindawi Publishing Corporation

    Gerald Evans

  68. Oral histoplasmosis masquerading as an invasive carcinoma

    Article • Journal of Oral and Maxillofacial Surgery, September 1995, Elsevier

    Gerald Evans

  69. Growth of Coagulase Negative Staphylococci in Peritoneal Dialysate Fluid

    Article • ASAIO Journal, July 1994, Wolters Kluwer Health

    Gerald Evans

  70. Clostridium sordellii infection and toxin neutralization

    Article • The Pediatric Infectious Disease Journal, August 1990, Wolters Kluwer Health

    Gerald Evans

  71. Mutation of Host Cell Determinants which Discriminate between Lytic and Persistent Mouse Hepatitis Virus Infection Results in a Fusion-resistant Phenotype

    Article • Journal of General Virology, December 1989, Society for General Microbiology

    Gerald Evans

  72. Factitious AIDS

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 1988, New England Journal of Medicine (NEJM/MMS)

    Gerald Evans